Blog
0
Dreams and Visions During A Cancer Journey
0

The patient and family have a choice earlier in their journey as to whether they wish to have a trained companion volunteer sit bedside near end of life. We ...

0
3 Topics Patients Should Discuss With Their Oncology Teams
0

Open communication between patients and providers is essential in cancer care. In fact, there are three important conversations patients should be having ...

0
Reiki and Cancer
0

I have been a Reiki practitioner since 1997. At the time, there were probably only 3 or 4 books written on the topic while today there are hundreds of ...

0
Breyanzi Cost Effective As Second-Line R/R DLBCL Treatment
0

CAR-T cell therapy Breyanzi (lisocabtagene maraleucel) has been found by researchers to be a cost-effective second-line treatment for patients with relapsed ...

0
FDA Approves On-Body Administration of Neulasta Biosimilar
0

The Food and Drug Administration (FDA) approved Udenyca Onbody, an injector for Udenyca (pegfilgrastim-cbqv) that attaches to the patient’s body, according ...

0
Patient With Skin Cancer Receives First Dose of Novel Cancer Vaccine
0

A patient in a phase 2 trial has received the first dose of a novel cancer vaccine in combination with Keytruda (pembrolizumab) as neoadjuvant (treatment ...

0
Keeping Faith During Cancer
0

Health has always been one of my priorities as a young child. Throughout my life, I have faced many obstacles, however, being diagnosed with colon cancer at ...

0
DONNA Marathon Weekend Returns February 2-4; Announces Calendar of Events
0

The DONNA Foundation today announced its calendar of events for the 2024 DONNA Marathon race weekend. Now in its 17th year providing a vibrant and exciting ...

0
Phase 3 Trial for Prostate Cancer Doses First Patient
0

The first patient has been dosed to begin the phase 3 CLARIFY trial, testing the diagnostic performance of the Cu-SAR-bisPSMAfor patients with prostate ...

0
Immune Disorders and Cancer
0

I have an immune disorder called selective IGA deficiency or SigAD. What it means is that the protein in the blood immunoglobulin is lacking a defense ...

0
Patients With Invasive Lobular Carcinoma Tend to Have Worse Outcomes
0

A recent study found that breast cancer-specific survival outcomes were worse for patients with invasive lobular carcinoma when compared with patients with ...

0
FDA Places Hold on Trial Evaluating TIL Therapy in NSCLC
0

The Food and Drug Administration (FDA) placed a clinical hold on the clinical trial evaluating the novel drug, LN-145 TIL, for patients with non-small cell ...

CML Alliance
Logo
Enable registration in settings - general
Compare items
  • Total (0)
Compare
0
Shopping cart